Bioscience Neutraceuticals, Inc. – ‘10-Q’ for 9/30/19 – ‘ZIP’

On:  Tuesday, 11/12/19, at 3:51pm ET   ·   For:  9/30/19   ·   Accession #:  1640334-19-2231   ·   File #:  1-36604

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Form 8-K                                            HTML    262K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     17K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     12K 
23: R1          Document and Entity Information                     HTML     39K 
30: R2          Consolidated Balance Sheets                         HTML     62K 
27: R3          Consolidated Balance Sheets (Parenthetical)         HTML     31K 
10: R4          Consolidated Statements of Operations (Unaudited)   HTML     72K 
22: R5          Statements of Stockholders Equity (Unaudited)       HTML     38K 
29: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML     64K 
26: R7          Organization and Description of Business            HTML     18K 
11: R8          Summary of Significant Accounting Policies          HTML     17K 
21: R9          Going Concern                                       HTML     18K 
15: R10         Note Payable                                        HTML     17K 
17: R11         Convertible Note Payable                            HTML     17K 
33: R12         Equity                                              HTML     17K 
24: R13         Related Transactions                                HTML     16K 
16: R14         Discontinued Operations                             HTML     31K 
18: R15         Subsequent Events                                   HTML     14K 
34: R16         Summary of Significant Accounting Policies          HTML     23K 
                (Policies)                                                       
25: R17         Organization and Description of Business (Details   HTML     15K 
                Narrative)                                                       
14: R18         Note Payable (Details Narrative)                    HTML     28K 
19: R19         Convertible Note Payable (Details Narrative)        HTML     44K 
31: R20         Equity (Details Narrative)                          HTML     45K 
28: R21         Related Transactions (Details Narrative)            HTML     21K 
12: R22         Discontinued Operations (Details)                   HTML     39K 
13: XML         IDEA XML File -- Filing Summary                      XML     53K 
32: EXCEL       IDEA Workbook of Financial Reports                  XLSX     27K 
 4: EX-101.INS  XBRL Instance -- devv-20190930                       XML    335K 
 7: EX-101.CAL  XBRL Calculations -- devv-20190930_cal               XML     30K 
 9: EX-101.DEF  XBRL Definitions -- devv-20190930_def                XML    105K 
 6: EX-101.LAB  XBRL Labels -- devv-20190930_lab                     XML    300K 
 8: EX-101.PRE  XBRL Presentations -- devv-20190930_pre              XML    242K 
 5: EX-101.SCH  XBRL Schema -- devv-20190930                         XSD     46K 
20: ZIP         XBRL Zipped Folder -- 0001640334-19-002231-xbrl      Zip     41K 

‘ZIP’   —   XBRL Zipped Folder — 0001640334-19-002231-xbrl

This is an XBRL Zipped Folder.

	Download this zipped .zip folder
Files:	devv-20190930.xml devv-20190930.xsd devv-20190930_cal.xml devv-20190930_def.xml devv-20190930_lab.xml devv-20190930_pre.xml